Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETELCALCETIDE for Hyperparathyroidism secondary: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,407 adverse event reports in the FDA FAERS database where ETELCALCETIDE was used for Hyperparathyroidism secondary.

Most Reported Side Effects for ETELCALCETIDE

Side Effect Reports % Deaths Hosp.
Underdose 246 9.0% 8 16
Shunt stenosis 202 7.4% 47 178
Nausea 182 6.6% 5 14
Product storage error 148 5.4% 0 1
Blood parathyroid hormone increased 142 5.2% 2 7
Hypocalcaemia 140 5.1% 13 31
Shunt occlusion 126 4.6% 19 104
Blood calcium decreased 119 4.3% 5 6
Diarrhoea 107 3.9% 5 13
Vomiting 102 3.7% 4 21
Circumstance or information capable of leading to medication error 82 3.0% 0 0
Death 78 2.8% 78 13
Drug ineffective 73 2.7% 4 2
Fall 71 2.6% 12 62
Cardiac failure 65 2.4% 29 50

Other Indications for ETELCALCETIDE

Product used for unknown indication (1,202) Hyperparathyroidism (40) Chronic kidney disease (35) Blood parathyroid hormone increased (21) Hyperparathyroidism tertiary (15) Secondary hyperthyroidism (10) End stage renal disease (9) Blood parathyroid hormone abnormal (8) Hypoparathyroidism secondary (6)

Other Drugs Used for Hyperparathyroidism secondary

CINACALCET (15,990) PARICALCITOL (2,607) CALCIFEDIOL (352) SENSIPAR (248) ZEMPLAR (61) CALCITRIOL (50) DOXERCALCIFEROL (34) DENOSUMAB (22) MIMPARA (22) EVOCALCET (18)

Related Pages

ETELCALCETIDE Full Profile All Hyperparathyroidism secondary Drugs ETELCALCETIDE Demographics ETELCALCETIDE Timeline